
Assessing the Older Patient with New Cognitive Symptoms
Mayo Clinic Talks
The Importance of Biomarkers in Managing Dementia Patients
This chapter discusses the significance of biomarkers in the management of dementia patients, including biomarkers for Alzheimer's disease such as neurodegeneration, amyloid, and tau. It explains functional neuroimaging tests like PET scans and CSF available biomarkers, and highlights the potential for future blood-based biomarkers. The chapter concludes with a summary of key points, emphasizing the role of primary care clinicians in delivering quality dementia care and the impact of a dementia diagnosis on different aspects of care.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.